Inventor · disambiguated record
Can Wang
Also filed as: WANG CAN
9 granted patents·2 pending applications·39 citations·filing 2012–2023
84Inventor score
Top patents by PatentIndex Score
11 records- 0191US9533988B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2015·Granted Jan 3, 2017·13 cites·8 claims
- 0290US9266883B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2014·Granted Feb 23, 2016·16 cites·13 claims
- 0378US10130629B2Pharmaceutical combinationsNOVARTIS AG·Filed 2016·Granted Nov 20, 2018·3 cites·7 claims
- 0478US9896449B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2016·Granted Feb 20, 2018·2 cites·1 claims
- 0578US9802917B2Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamideBUSCHMANN NICOLE·Filed 2016·Granted Oct 31, 2017·2 cites·15 claims
- 0676US11208398B2Chemical process for preparing phenylpiperidinyl indole derivativesNOVARTIS AG·Filed 2019·Granted Dec 28, 2021·2 cites·26 claims
- 0766US11578053B2Chemical process for preparing phenylpiperidinyl indole derivativesNOVARTIS AG·Filed 2021·Granted Feb 14, 2023·0 cites·10 claims
- 0863US8470878B2Heterocyclic sulfonamide derivativesPODDUTOORI RAMULU·Filed 2012·Granted Jun 25, 2013·1 cites·12 claims
- 0960US2025101006A1Process for the synthesis of pyrazolyl derivatives useful as anti-cancer agentsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1056US10507201B2Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2019·Granted Dec 17, 2019·0 cites·17 claims
- 1146US2018185341A1Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Can Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →